The Vulnerable Elders Survey (VES-13) is a simple function based frailty screening tool that can be also administered by the nonclinical personnel within 5 minutes and has been validated in the out-and in patient clinic and acute medical care settings. the aim of the study was to validate theaccuracy of the VES-13 screening method for predicting the frailty syndrome based on a CGA in polish surgical patients. material and methods. We included prospectively 106 consecutive patients ≥65, that qualify for abdominal surgery (both due to oncological and benign reasons), at the tertiary referral hospital.We evaluated the diagnostic performance of VES-13 score comparing to the results from the CGA, accepted as the gold standard for identifying at risk frail elderly patients. Results. The prevalence of frailty as diagnosed by CGA was 59.4%. There was significantly higher number of frail patients in the oncological group (78% vs. 31%; p<0.01). According to the frailty screening methods, the frailty prevalence was 45.3%. The VES-13 score had a 60% sensitivity and 78% specificity in detecting frailty syndrome. The positive and negative predictive value was 81% and 57%, respectively. The overall predictive capacity was intermediate (AUC=0.69) Conclusions. At present, the VES-13 screening tool for older patients cannot replace the comprehensive geriatric assessment; this is due to the insufficient discriminative power to select patients for further assessment. It might be helpful in a busy clinical practice and in facilities that do not have trained personal for geriatric assessment.
The aging population is a common phenomenon both in the industrialized and in developing countries. The progress in medicine and related with it extension of life expectancy, causes that the number of elderly patients with cancer increases and will increase substantially in the coming years.Polish society is aging in an average of 0.1-0.2% per year. According to Polish Central Statistical Office data, in Poland in 1996, people over 65 years of age accounted for 11.2% of the total population, once in 2008 it increased to 13.5%. It is predicted that in Poland to the year 2030 the percentage of people over 65 years will rise to the 24%. Most growing "segment" of this population will be people after 85 years of age (1) .
This group of patients is very heterogeneous with regard to comorbidity and physical reserves. Therefore, a routine format of medical history, physical examination and biochemical and imaging tests are often ineffective in finding the optimal andtailored treatment. To help guide treatment decisions a comprehensive geriatric assessment (CGA) was introduced, aiming the detection of patients with decreased physiological reserves, arising from cumulative deficits in several physiological systems and resulting in a diminished resistance to stressors (2, 3) . It objectively appraises the 127 Vulnerable elderly survey 13 as a screening method for frailty in polish elderly surgical patient health status of elderly people, focusing on somatic, functional, and psychosocial domains with proven value in geriatric medicine (4) .
However, the CGA procedure requires experience and is time-consuming, taking into consideration limited time available and the workload of more and more complex patients' diagnostic/treatment plan. Moreover, some older patients may be in poor health and not to be able to withstand extensive assessing process. Therefore, a variety of screening methods were developed to identify vulnerable patients who should subsequently receive a full geriatric assessment. The Vulnerable Elders Survey (VES-13) (5) is one of the mostly usedscreening tests. It is a simple function based tool that can be also administered by the nonclinical personnel within 5 minutes. The survey has been validated in the out-and in patient clinic and acute medical care settings (6, 7, 8) . Moreover, it does not require knowledge of the pre-existing conditions.
The aim of this prospective study was to assess theaccuracy of the VES-13 screening method for predicting the frailty syndrome based on a CGA in polish surgical patients.
MATERIAL AND METHODS

Study population
Between January 2013 and October 2013 106 patients (median age 74, range 63-90 years old) aged 65 or more were enrolled into the prospective study. Fourpatients refused to participate in the study. All patients were qualified for abdominal surgery at the tertiary referral hospital. The baseline characteristics of the patients are reported in tab. 1. 42 patients were with cancer and 64 with benign disease.
Selection criteria
Inclusion criteria (patients must meet all criteria): patients were enrolled if aged ≥65 and receiving elective abdominal surgery under general anaesthesia.
Exclusion criteria: abdominal hernia surgery, peritoneal carcinomatosis.
Screening tests and comprehensive geriatric assessment
Prior to surgery VES-13 frailty screening tests was carried out (tab. 2). Finally, all patients had also a standard CGA, being the gold standard for subsequent comparisons. The CGA comprised validated methods such as: activities of daily living (ADL) (9), instrumental activities of daily living (IADL) (10), the Blessed Orientation-Memory-Concentration (BOMC) Test (11) and Clock Drawing Test (CDT-test) (12), Charlson Comorbidity Scale (13), Geriatric Depression Scale (14) , Timed Up and Go (TUG) (15) , full nutritional assessment (MNA) (16) . The results of each of the scores were recorded. In addition, each test (17) .
Statistical analysis
Qualitative and quantitative data were used to describe the study results. Quantitative parameters are expressed as the mean value ± standard deviation or median (range) as appropriate. The remaining cases were summarized as counts and percentages. The data were analyzed using the STATISTICA 10.0 software suite (StatSoft). The ShapiroWilk W and the Kolmogorov-Smirnov tests, with the Killiefors correction, were used to verify the normality of the distribution of the results. Based on these analyses, the data were analysed using parametric or non-parametric tests. A Receiver Operating Characteristic (ROC) curvewas used to evaluate the diagnostic performance of the screening tools for frailty, withthe CGA being the gold standard. The area under the curve (AUC) reflected the predictiveability of the screening testsin the detection of frailty. A statisticalcomparison of both tests was carried out as described by Hanley and McNeil (18, 19) . Moreover, the sensitivity, specificity and positive/negative predictivevalues of the above tests were also estimated. Internal analysis was also performed within the three subgroups 65-79 years and 80+ years old. Statistical significance was defined as a two-sided p ≤ 0.05.
RESULTS
The prevalence of frailty as diagnosed by CGA was 59.4% (63 patients). Among this group 32 patients were female (57.1%) and 31 (62%) were male (p>0.05). There was significantly higher number of frail patients in the oncological group in comparison to the benign disease group (78% vs 31%; p<0.01) According to the frailty screening methods; the frailty prevalence was 45.3% (48 patients: 25 female and 23 male) (VES-13).
Comparison of predicted frailty risk
The efficacy of the scores for predicting frailty can be defined as sensitivity and its efficacy in predicting a fit (non-frail) person defined as specificity. The value of the VES-13 score is shown in tab. 4. These results are 129 Vulnerable elderly survey 13 as a screening method for frailty in polish elderly surgical patient presented at cut off value used in primary publication (tab. 2). Table 5 summarise the sensitivity, specificity, PPV, NPV and accuracy of VES-13 screening method for predicting frailty based on CGA including internal analysis within the subgroups 65-79 years, 80+ years old. We can observe significantly higher sensitivity in the 80+ group. NPV is 0% in the 80+ group because all patients from this group were assessed as frail based on the CGA.
The area under the curve, in the ROC plot, is presented in tab. 6, showing moderateoverall predictive value of the VES-13 score and moderate in case of cancer group and young elderly patients (AUC 0.76 and 0.71 respectively). 
DISCUSSION
The prevalence of frailty syndrome based on CGA was 59.4% in our study. In the published meta-analysis and systematic reviewsa median of 68% (range 28-94%)of patients were considered frail. However, most of the studies assessed elderly oncological patients in the in-and outpatient settings. This is also well visible in our study when we consider only oncological patients; the prevalence of frailty was significantly higher (78% of cancer group). In turn, in the published literaturethe median prevalence of frailty based on the screening scores is 49% (range 12-83%) (20) . Similarly, in our study the VES-13 score revealed frailty syndrome in 45.3% patients. Table 7 summarise the sensitivity and specifity of screening tests from recently published studies in comparison to our results. This is the first study assessing prospectivelythe effectiveness of VES-13 score inpolish elderly patients qualified for abdominal surgery. Comparison with other studies was difficult because both the CGA instruments, cut-off values to define frailty and study population differ in some papers considerably due to lack of golden standard. However, as we can see based on tab. 7 our results are substantially similar to previously published in Europe and United States.
The results show that the VES-13 score had not very high sensitivity and specificity. This is also not surprising because it assess mainly functional status and can not precisely identify impairments in other geriatric domains such as mood, nutritional status or cognitive level, although all these domains are somehow connected to each other.
Other important characteristic of a screening tool isalso the ability to exclude the possibility of vulnerability, which is equivalent to negative predictive value. The NPV of 57% means that less than ahalf of patients were unjustly considered fit by screening score. This situation in out study is much worse in cancer patients' group (38%) but much better in benign disease group (81%). In the known meta-analysis there is a wide variety of results beginning with NPV of 18% and finishing with NPV being at the level of 88% (20) .
Age has also an influence on predictive value of the screening test, what was shown in tab.5. With the higher age, the sensitivity increased significantly. It is certainly connected with the number of impaired domains, which are observed in old elderly patients. The higher the number of overall CGA score, the easier for the screening test to detect frailty. The NPV was 0% in case of 80+ group. This is due to the fact, that a non-frail patient in this population is rarity. The average CGA score was significantly lower in the 65-79 group than in 80+ group (1.9 vs. 3.1; p<0.05).
Comprehensive geriatric assessment is an established method for evaluating and optimising diagnostic and treatment plan. A Cochrane meta-analysis of 22 trials with over 10,000 patients, comparing CGA with standard care, revealed increase in relative risk of being both alive and discharged in their own homes at 6 and 12 months follow-up in case of patients with preoperative CGA assessment (4). It is also recommended routinely in surgical practice, enhancing the decision process of qualifying patient for a surgical intervention and reducing inappropriate age-related inequity (22). However, the VES-13 score is not so effective as a screening tool, having only moderate overall predictive value (AUC=0.69) or fair predictive value in case of oncological patients (AUC=0.76) and at present it cannot replace the full comprehensive geriatric assessment. It is also important to mention that the VES-13 score was originally developed to predict death and functional decline over 1-to 5-year time frame. However, it was validated and widely used as potential screening tool for patients requiring comprehensive geriatric assessment (5, 6, 23) .
The limitationsof this study include the fact that the data are from one clinical site (tertiary care hospital) and the population sample was not characteristic of the general population. Furthermore, inclusion in the study was limited only to the patients undergoing abdominal cancer surgery.
CONCLUSIONS
At present, the VES-13 screening tool for older patients cannot replace the comprehensive geriatric assessment; this is due to the insufficient discriminative power to select patients for further assessment. It might be helpful in a busy clinical practice and in facilities that do not have trained personal for geriatric assessment.
